CME

CME


Latest Episodes

ATTRv-PN: A Complicated Disease With a Poor Prognosis
April 23, 2024

Guest: John Berk, MD Guest: Sami Khella, MD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interview

Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
April 23, 2024

Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectu

The Multiple Faces of ATTRv-PN
April 23, 2024

Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectu

Diagnosing ATTRv-PN: What's in Your Toolbox?
April 23, 2024

Guest: Sami Khella, MD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexiti

Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
April 15, 2024

Host: Omer Abdul Hamid, MD Guest: Nancy Kuntz, MD Guest: Migvis Monduy, MD There are many unmet needs associated with the use of anti-inflammatory glucocorticoids when treating Duchenne muscular dystrophy, or DMD. These include multiple,

GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events
April 15, 2024

Host: Jeffrey V. Matous, MD Guest: Donna Catamero, NP Guest: Ajai Chari, MD GPRC5D-directed therapy is associated with impressive overall response rates and substantially positive clinical outcomes in heavily pretreated relapsed/refracto

Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
April 15, 2024

Host: Carl Regillo, MD Guest: Jennifer I. Lim, MD, FARVO What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the bi

GET REAL: A Guide to Evolving Treatment of nAMD and DME Using Real-World Data
April 11, 2024

Host: Arshad M. Khanani, MD, MA Guest: Theodore Leng, MD, MS Lets get real. Clinical trial data can be difficult to apply to retina practices. Patient populations are often limited, and injection schedules are strictly enforced in clinical

South Asians With IBD: Underrepresented and Underappreciated
April 09, 2024

Host: Tauseef Ali, MD, FACG, AGAF Host: Sabina Ali, MD Host: Neil Nandi, MD, FACP Host: Tina Aswani-Omprakash, MPH A South Asian pediatric gastroenterologist discusses the epidemiology of IBD, distinct phenotypes, the latest clinical

OSA: Exploring the Impact on Morbidity and Mortality
March 29, 2024

Host: Alcibiades J. Rodriguez, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of O